Related Experiment Video
Updated: Jun 10, 2026
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
Aminaphtone for light bleeding in patients under oral anticoagulation
José Maria Pereira de Godoy1, Gustavo Paludetto, Bianca R Testoni
1Angiology and Vascular Surgery Service of the Medicine School in São José do Rio Preto- SP (FAMERP).
Background:
Bleeding is a common complication of oral anticoagulation therapy.
Objective:
The present study evaluated the use of aminaphtone in patients with minor bleeding while taking warfarin.
Methods:
Seven patients suffering from bleeding of the nose and gums, who were taking therapeutic doses of warfarin, were included in the study.
Results:
The patients were prescribed 75 mg aminaphtone twice daily. For 5 of these patients the bleeding was controlled within 48 h, for 1, within 96 h and for the other, a satisfactory reduction was obtained.
Conclusion:
Patients with minor bleeding during treatment using oral anticoagulation, who are free from risk of other complications, can benefit from the use of aminaphtone as an initial therapeutic option.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
01:22Aneurysm IV: Nursing Management
01:30Venous Thrombosis IV: Nursing Management
01:30Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...